FI980853A7 - Uusi DNA ja menetelmä proteiinin valmistamiseksi käyttäen DNA:ta - Google Patents
Uusi DNA ja menetelmä proteiinin valmistamiseksi käyttäen DNA:ta Download PDFInfo
- Publication number
- FI980853A7 FI980853A7 FI980853A FI980853A FI980853A7 FI 980853 A7 FI980853 A7 FI 980853A7 FI 980853 A FI980853 A FI 980853A FI 980853 A FI980853 A FI 980853A FI 980853 A7 FI980853 A7 FI 980853A7
- Authority
- FI
- Finland
- Prior art keywords
- dna
- making protein
- new
- new dna
- protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Crystallography & Structural Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8235928A JPH1057071A (ja) | 1996-08-19 | 1996-08-19 | 新規ｄｎａ及びそれを用いた蛋白質の製造方法 |
| PCT/JP1997/002859 WO1998007840A1 (fr) | 1996-08-19 | 1997-08-19 | Nouveaux adn et procede de production de proteines a l'aide de ces derniers |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI980853A0 FI980853A0 (fi) | 1998-04-17 |
| FI980853L FI980853L (fi) | 1998-06-15 |
| FI980853A7 true FI980853A7 (fi) | 1998-06-15 |
Family
ID=16993321
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI980853A FI980853A7 (fi) | 1996-08-19 | 1997-08-19 | Uusi DNA ja menetelmä proteiinin valmistamiseksi käyttäen DNA:ta |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0874045A1 (enExample) |
| JP (1) | JPH1057071A (enExample) |
| KR (1) | KR20000064276A (enExample) |
| CN (1) | CN1198776A (enExample) |
| AU (1) | AU718458B2 (enExample) |
| CA (1) | CA2235148A1 (enExample) |
| FI (1) | FI980853A7 (enExample) |
| HU (1) | HUP0001837A3 (enExample) |
| NO (1) | NO981748L (enExample) |
| NZ (1) | NZ330400A (enExample) |
| WO (1) | WO1998007840A1 (enExample) |
| ZA (1) | ZA977402B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL117175A (en) | 1995-02-20 | 2005-11-20 | Sankyo Co | Osteoclastogenesis inhibitory factor protein |
| US6919434B1 (en) | 1995-02-20 | 2005-07-19 | Sankyo Co., Ltd. | Monoclonal antibodies that bind OCIF |
| WO1998028424A2 (en) | 1996-12-23 | 1998-07-02 | Immunex Corporation | Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily |
| NZ332995A (en) | 1997-04-15 | 2000-07-28 | Snow Brand Milk Products Co Ltd | A protein which binds to osteoclastogenesis inhibitory factor (OCIF) |
| BR9808545A (pt) | 1997-04-16 | 2000-05-23 | Amgen Inc | ácido nucleico isolado, vetor de expressão, célula hospedeira, processos para produzir uma proteìna de ligação da osteoprotegerina, para detectar a presença de uma proteìna de ligação à osteoprotegerina em uma amostra biológica, para avaliar a capacidade de um composto candidato de ligar-se a uma proteìna de ligação da osteoprotegerina e de um composto de teste para aumentar ou reduzir a ligação da proteìna de ligação da osteoprotegerina a odar, para regular a expressão de uma proteìna de ligação da osteoprotegerina em um animal e para prevenir ou tratar de doença óssea em um mamìfero, polipeptìdeo, protéina de ligação da osteroprotegerina purificada e isolada, ou seu fragmento, análogo ou derivado, e, anticorpo ou seu fragmento |
| US6316408B1 (en) | 1997-04-16 | 2001-11-13 | Amgen Inc. | Methods of use for osetoprotegerin binding protein receptors |
| JP4268684B2 (ja) | 1997-09-24 | 2009-05-27 | 第一三共株式会社 | 骨代謝異常症の診断方法 |
| ATE412746T1 (de) | 1998-05-14 | 2008-11-15 | Immunex Corp | Verfahren zur hemmung der wirkung der osteoklasten |
| PL347559A1 (en) | 1998-10-28 | 2002-04-08 | Snow Brand Milk Products Co Ltd | Remedies for bone metabolic errors |
| AUPQ167599A0 (en) * | 1999-07-19 | 1999-08-12 | St. Vincent's Institute Of Medical Research | Inhibitor of osteoclast precursor formation |
| AU7720600A (en) * | 1999-09-27 | 2001-04-30 | Eli Lilly And Company | Osteoprotegerin regulatory region |
| RU2324705C2 (ru) | 2001-04-03 | 2008-05-20 | Сосьете Де Продюи Нестле С.А. | Остеопротегерин, применение его для изготовления фармацевтической композиции (варианты) и получения пищевого продукта (варианты) и корма для животных, пищевой продукт, корм для животных и фармацевтическая композиция для профилактики или лечения расстройств, связанных с костным ремоделированием, и/или иммунных расстройств |
| DK1572874T3 (da) | 2001-05-25 | 2013-12-16 | Human Genome Sciences Inc | Antistoffer, der immunospecifikt binder til TRAIL receptorer |
| US7718776B2 (en) | 2002-04-05 | 2010-05-18 | Amgen Inc. | Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL117175A (en) * | 1995-02-20 | 2005-11-20 | Sankyo Co | Osteoclastogenesis inhibitory factor protein |
| US6369027B1 (en) * | 1995-12-22 | 2002-04-09 | Amgen Inc. | Osteoprotegerin |
-
1996
- 1996-08-19 JP JP8235928A patent/JPH1057071A/ja not_active Withdrawn
-
1997
- 1997-08-18 ZA ZA977402A patent/ZA977402B/xx unknown
- 1997-08-19 FI FI980853A patent/FI980853A7/fi unknown
- 1997-08-19 CN CN97191093A patent/CN1198776A/zh active Pending
- 1997-08-19 KR KR1019980702740A patent/KR20000064276A/ko not_active Ceased
- 1997-08-19 EP EP97935810A patent/EP0874045A1/en not_active Withdrawn
- 1997-08-19 CA CA002235148A patent/CA2235148A1/en not_active Abandoned
- 1997-08-19 AU AU38661/97A patent/AU718458B2/en not_active Ceased
- 1997-08-19 HU HU0001837A patent/HUP0001837A3/hu unknown
- 1997-08-19 WO PCT/JP1997/002859 patent/WO1998007840A1/ja not_active Ceased
-
1998
- 1998-04-17 NO NO981748A patent/NO981748L/no unknown
- 1998-05-07 NZ NZ330400A patent/NZ330400A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998007840A1 (fr) | 1998-02-26 |
| ZA977402B (en) | 1999-02-18 |
| FI980853L (fi) | 1998-06-15 |
| AU718458B2 (en) | 2000-04-13 |
| NO981748D0 (no) | 1998-04-17 |
| NO981748L (no) | 1998-06-18 |
| MX9803086A (es) | 1998-11-29 |
| CA2235148A1 (en) | 1998-02-26 |
| JPH1057071A (ja) | 1998-03-03 |
| CN1198776A (zh) | 1998-11-11 |
| KR20000064276A (ko) | 2000-11-06 |
| EP0874045A1 (en) | 1998-10-28 |
| AU3866197A (en) | 1998-05-11 |
| NZ330400A (en) | 1999-05-28 |
| FI980853A0 (fi) | 1998-04-17 |
| HUP0001837A3 (en) | 2002-09-30 |
| EP0874045A4 (enExample) | 1998-11-18 |
| HUP0001837A2 (hu) | 2000-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI974016L (fi) | Proteiinisideaine ja menetelmä proteiinisideaineen muodostamiseksi | |
| FI973402L (fi) | Uusia proteiineja ja menetelmiä proteiinien tuottamiseksi | |
| FI972429A0 (fi) | Menetelmä ja laite DNA:n sekvensoimiseksi ja DNA:n identifioimiseksi | |
| DE69530277D1 (de) | Verfahren zur auswahl von übertragungsvorzügen | |
| IS8368A (is) | Ný aðferð | |
| FI970648L (fi) | Menetelmä nukleiinihappojen jakelemiseksi | |
| IL120337A0 (en) | Method for joining DNA fragments | |
| FI980853L (fi) | Uusi DNA ja menetelmä proteiinin valmistamiseksi käyttäen DNA:ta | |
| GB2293883B (en) | Method for measuring protein concentration using a protein biosensor | |
| AU1683795A (en) | Method for determining protein tertiary structure | |
| DE69514851D1 (de) | Interatomares Messverfahren | |
| FI961879L (fi) | Aromatisointimenetelmä | |
| IS5106A (is) | Ný aðferð | |
| FI940316L (fi) | Menetelmä heraproteiinien fraktioimiseksi | |
| EE03643B1 (et) | Meetod ja süsteem sümbolijada vastuvõtmiseks | |
| FI971100L (fi) | Menetelmä yhdistelmä-DNA-proteiinien, plasmidien ja modifioitujen solujen tuottamiseksi | |
| FI964657L (fi) | Geenitestausmenetelmä | |
| NO960766D0 (no) | Nytt protein og fremgangsmåte for fremstilling av dette | |
| FI980945L (fi) | Menetelmä proteiinien eristämiseksi ja muuntelemiseksi | |
| FI972055L (fi) | Syljen analysointimenetelmä | |
| FI982487L (fi) | Menetelmä ja järjestelmä V5-liitännän hallitsemiseksi | |
| DE69724736D1 (de) | Prozessablaufsteuerung | |
| FI954684L (fi) | Imidobisfosforihapot, menetelmä niiden valmistamiseksi ja niiden käyttö | |
| FI100322B (fi) | Menetelmä kaavinpalkkijärjestelyn käyttöön ja kaavinpalkkijärjestely | |
| FI980758L (fi) | Menetelmä vanerin valmistamiseksi |